LifeMD, Inc. (NASDAQ:LFMDP) Short Interest Down 62.5% in January

LifeMD, Inc. (NASDAQ:LFMDP) was the target of a significant drop in short interest in January. As of January 31st, there was short interest totalling 300 shares, a drop of 62.5% from the January 15th total of 800 shares. Based on an average daily volume of 2,000 shares, the short-interest ratio is presently 0.2 days.

LifeMD Stock Up 0.8 %

Shares of NASDAQ:LFMDP traded up $0.18 during trading on Wednesday, hitting $22.75. 1,135 shares of the company’s stock were exchanged, compared to its average volume of 2,593. The firm has a 50-day moving average price of $22.39 and a two-hundred day moving average price of $22.24. LifeMD has a 1-year low of $18.21 and a 1-year high of $25.00.

LifeMD Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Friday, January 3rd were issued a dividend of $0.5547 per share. This represents a $2.22 dividend on an annualized basis and a yield of 9.75%. The ex-dividend date of this dividend was Friday, January 3rd.

About LifeMD

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.